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Abstract 
This manuscript provides a response to a recent report by Mazzone et al. available online on                               
arXiv that, in turn, tentatively aims at demonstrating the inefficacy of proton boron capture in                             
hadrotherapy. We clarify that Mazzone et al. do not add any scientific or technical insights to the                                 
points extensively discussed in the original manuscript by Cirrone et al., and/or in the series of                               
iterations had with the Referee, which ultimately lead to the publication of our original and                             
pioneering experimental work. Here we summarize some of the key points of the long scientific                             
debate we had during the review process of paper by Cirrone et al., which are very similar to the                                     
considerations presented by Mazzone et al.. In conclusion, no quantitative explanation of our                         
robust experimental achievements presented in Cirrone et al. is provided in Mazzone et al. 
 
Introduction 
A work recently published by our group [1] experimentally demonstrates for the first time the                             
potential role of the p+11B -> 3a (for brevity, p-B) reaction in the biological enhancement of                               
proton therapy effectiveness. The work reports robust experimental data in terms of clonogenic                         
 curves and chromosomal aberrations and unambiguously shows the enhancement when cells                     
were exposed to a clinical proton beam subject to treatment with sodium boroncaptate (BSH).                           
Moreover, the larger occurrence of complex-type of chromosomal exchanges highlights the                     
presence of an LET larger than that of protons alone, possibly related to alpha-particles                           
generated by the pB fusion reaction (see for instance Sumption et al., 2015) 
At the same time, we have openly and clearly reported in [1] that analytical calculations,                             
performed on the basis of the well known total production cross section curves, are not able to                                 
explain the effect in a macroscopic way, i.e. solely in terms of a trivial increase in the total dose                                     
presumably released in the cells by the generated alpha-particles. 
In this document, we report all the steps of the scientific discussion carried out during the review                                 
process of Scientific Reports based on the points raised by the Referees. This includes several                             
calculations and considerations exchanged with the Referees between April 2017 and December                       
2017, i.e. well before our publication [1]. 
The conclusion of such a long scientific debate with the Referees was that, however desirable, we                               
were not able to provide a simple analytical computation to explain quantitatively our                         
experimental results, for instance by correlating the biological effect with the total number of                           
α-particles that is expected in our experimental conditions. 
A work recently published on arXiv by Mazzone et al. [2], just one month after our publication,                                 
reports trivial calculations on p-B generated alpha-particles, incidentally very similar to those                       
privately exchanged between us and the reviewers. The authors of [2] have no choice but                             
concurring on what we already admitted with the reviewers of [1], reaching the same conclusion                             
as ours on the well known involved nuclear processes, while adding nothing on the debate we                               
started. An alternative interpretation of our experimental data, with sound physical bases and a                           
thorough understanding of the complexity of the underlying radiobiology, is totally missing in                         
[2]. This would have been much more useful to us and the scientific community interested in the                                 
potential improvement of protontherapy efficacy, experimentally demonstrated for the first time                     
by our group as reported in [1].   
The only apparent “novelty”, although misleading, added by the authors of [2] is the introduction                             
of an argument based on the p-16O reaction that, as well known, is an important channel related                                 
to the production of alpha particles in water. They report (Figure 2 in Mazzone et al.) the                                 
probability per unit length of proton interaction with water elements, including BSH at the                           
density used in our experiment [1]. It is trivial that alpha-particles generated in the p+16O                             
 reaction dominate with respect to those generated via p+11B fusion, and this is obviously due                             
to the high and natural concentration of Oxygen in water. Furthermore, this is also clearly                             
misleading since BSH does not contain 16O. Figure 2 of Mazzone et al. is hence intended to                                 
deceive, leading the reader to think that the presence of oxygen in water (or in the human body)                                   
is responsible for alpha particle generation and dose increase. Alpha particles generated by                         
protons interaction with Oxygen (or any other element naturally contained in the body), as well                             
known by any expert in the field, are present and obviously already studied in the development                               
of biological treatment planning for protontherapy. This has not related at all with the presence                             
of BSH (or boron) in the cells used in our experimental runs and, in any case, it is an effect                                       
always present (with and without BSH or B). 
 
Data reported in this work aim at clarifying that the discussed radiobiological phenomena in our                             
paper [1] will have to be better explained from an analytical/numerical point of view and, at the                                 
same time, that their interpretation cannot be merely carried out with a classical, non                           
sub-micrometric approach. 
 
p+11B scientific literature related to Medical Physics applications 
In 2014, a paper by Y. Do-Kun et al [3] reported on Monte Carlo simulations supporting the use                                   
of p + 11B → 3α nuclear fusion reaction to enhance proton biological effectiveness                   
exclusively in the tumour region through the generation of short-range high-LET alpha particles.                         
They also proposes to develop a tumor-treatment monitoring technique using prompt gamma                       
rays emitted from 11B atoms interaction with incident protons [4-9].  
In the subsequent period we have published a number of theoretical papers [7-9] clarifying some                             
points on the dose enhancement presented in [3] (in fact by proposing a few corrections,                             
especially based on the fact that the authors of [3] had used unrealistic B concentrations in the                                 
body) and on the origin of the prompt gamma rays (10B and not 11B). 
On January 18th, 2018 we published the first pioneering experimental data [1] demonstrating in                           
vitro the predicted effect and suggesting the role of the p+11B reaction in the observed                             
enhancement of proton-induced clonogenic cell death and DNA damage. In particular, we                       
concluded our paper with the sentence: “The radiobiological data reported in this work suggest                           
that the p + 11B → 3α reaction as being responsible for the observed increase in the                         
biological effectiveness of a clinical proton beam. However desirable, we cannot currently                       
 provide a simple analytical computation able to explain our results, for instance by correlating the                             
biological effect with the total number of α-particles that can be expected to be generated under                               
our experimental conditions.” The discussion on the macroscopic demonstration of the effect is,                         
hence, left  open to further investigation. 
On February 26th, 2018 the paper by Mazzone et al. [2] appeared on arXiv. The manuscript                               
reports obvious physical considerations already raised in the discussions we previously had with                         
the Referees of Scientific Report during the review process of [1]. Furthermore, remarks                         
presented in [2] are very similar to some of the discussions carried out with the Referees both in                                   
terms of content and form. 
Based on this premise and for the sake of clarity, we here report the outstanding aspects of the                                   
debate we had with the Reviewers of Scientific Reports, where almost all calculations reported in                             
the paper by Mazzone et al. where already anticipated. We also underline that the analytical                             
considerations we had carried out and discussed were removed from the original paper, in                           
accordance with the Referees’ request. 
The discussions reported in the following paragraph have an important scientific value as they                           
emphasise all the issues still to be solved and understood in such recently emerging field. 
 
Summary of the Correspondence with the Scientific Reports’ Referees on the                     
quantification of the generated alpha particles 
We here report the summary of four different iterations we had with the Scientific Reports’                             
Referees who had sent us their comments on April 3rd, July 20th, November 8th and December                               
15th 2017. This summary refers exclusively to the discussion raised by one of the Referee on the                                 
the alpha particle estimations and on its potential inconsistency with the corresponding                       
radiobiological estimates from our experimental results. 
 
Since the first interaction and for all the subsequent reviews, one of the Referees criticised our                               
work for the lack of a dosimetric evaluations i.e. for the estimation of the dose released by the                                   
alpha particles produced in the considered reaction. In fact, the omission of these considerations,                           
in the first manuscript version, was intentional: the work was conceived as a proof-of-principle,                           
with the only goal to demonstrate/verify experimentally the biological effect.  
The statement that the dose released is one-to-one connected with the corresponding biological                         
effect, is wrong as easily understandable by an expert in the field. The mere macroscopic concept                               
 of absorbed dose, in fact, does not allow to explain alone the biological effects of radiations that,                                 
on the opposite, must be analysed by the use of micro and nano dosimetric approaches.                             
Nevertheless, at that time, we decided to show the Monte Carlo and analytical calculations we                             
had already performed,  in the attempt to explain with a trivial approach the observed effect. 
Using the Geant4 Monte Carlo Hadrontherapy [10-14] application we have simulated the                       
beamline in detail and then evaluated the the proton and neutron spectra at the cell position.                               
Using the well known total cross section of the 11B(p,a)2a reaction [15-16] we then evaluated the                               
number N of total alphas produced with the formula: 
 
 
where the experimental total reaction cross section σ(E) is those reported in Figure 1 [15-16],                             
the Boron density is assumed to be 8E-5 gr/cm3 (corresponding to the one used during the                               
experiment) and the layer cells thickness is assumed to be 100 um.  
 
 
 Figure 1: experimental total cross section of the 11B(p,a)2a reaction. 
  
The considered reaction shows a maximum cross section of 1.2 b at the proton energy of 675                                 
keV, as reported in Figure 1. The number of alpha particles as a function of the proton depth in                                     
water is reported in Figure 2 along with the experimental Spread Out Bragg Peak.  
Moreover, Monte Carlo simulations allowed us to estimate the increment of physical dose due to                             
alpha particle production. The resulting alpha particle dose is of the order of 10^-7 Gy in the                                 
middle of the SOBP, thus apparently negligible with respect to the primary proton dose. For the                               
sake of clarity Figure 2 shows the absolute dose spread out Bragg peak when 8.47E11 primary                               
proton histories are simulated. In the same figure the correspondent absolute dose released by                           
the generated alpha particles is shown.  
 
 
Figure 2: ​Simulated absolute dose released by the proton beam and by only alpha particles                             
(log-scale) 
 
 As the reader can easily argue, our first estimation of the total number of alpha particles                               
produced was already performed in April 2017. It should be noted that Figure 2 is very similar to                                   
Figure 6 of the paper by Mazzone et al [2].  
 
During our several iterations with the Reviewers, lasting for about nine months (April-December                         
2017), we have also discussed and evaluated other potential source of alpha particles. Among                           
these, we have discussed the contribution of neutron interaction with 10B based on the very well                               
known 10B(n,7Li)a channel, the presence of the 10B(p, a)7Be channel and the possibility of a                             
locally increased density of BSH in the cells with respect to the medium reported in literature                               
[17]. 
 
We concluded our various responses admitting our obvious difficulty in finding an analytical                         
explanation of our robust experimental results. On the contrary, considering the robustness of                         
our experimental data and given the vast uncertainties in terms of boron localization within the                             
cells (similarly to the 70-year old history of BNCT), we expressed our conviction that this point                               
will be elucidated in future theoretical papers by the international community of experts in the                             
field. Unfortunately the Referee was against this position and concluded in December 2017 that                           
the Authors were not able, at this stage, to demonstrate the effect and that this should have been                                   
clearly emphasised in the conclusion. We accepted such a Referee’s final remark and wrote a                             
sentence explicitly and clearly admitting that the role of p-11B reaction in the work is probable                               
but remains an hypothesis that must be still investigated. 
The final sentence reported in our original paper is [1]: “The radiobiological data reported in this                               
work suggest that the p + 11B → 3α reaction as being responsible for the observed increase in                           
the biological effectiveness of a clinical proton beam. However desirable, we cannot currently                         
provide a simple analytical computation able to explain our results, for instance by correlating the                             
biological effect with the total number of α-particles that can be expected to be generated under                               
our experimental conditions. A possible approach could be trying to calculate the increase in the                             
overall dose and/or LET due to such particles. The current knowledge of biological radiation                           
action has nonetheless established that, the biological effects of low-energy high-LET radiations                       
cannot be interpreted solely on the basis of macroscopic concepts like the absorbed dose or the                               
average LET distributions. This is due to the intrinsically inhomogeneous nature of energy                         
deposition events along radiation tracks, which becomes more significant with their increasing                       
 ionization density. Therefore, micro- and nano-dosimetric approaches must be taken into                     
account to analyse the effects arising at cellular level. In addition, the role of extra-targeted                             
phenomena, such as the bystander effect whereby cells that have not been traversed directly by                             
radiation tracks may express cytogenetic damage, is still largely undetermined in such scenario,                         
thereby contributing to the overall uncertainty between the physical dose distribution at the                         
micro or nano-dosimetric level and at the cellular one”. 
 
Conclusions 
The aim of this paper is to openly show all the analytical and Monte Carlo studies performed                                 
during the preparation of our original paper [1] and during its review process, hence well before                               
the publication of the paper by Mazzone et al [2]. These calculations were explicitly requested by                               
one of the two Referees in the attempt of explaining the observed enhancement of a clinically                               
used proton beam by means of classical arguments connected to the concept of the released                             
dose. We decided to present these results fully and reporting the original Referees’ questions and                             
authors’ replies in the hope of a better clarification on the fact that trivial and classical                               
calculations performed with a nuclear approach are not sufficient to explain the experimentally                         
observed effect. 
The work proposed by Mazzone et al., besides the fact that does not provide any new scientific                                 
insights with respect to what already stated in our original paper, is limited to a number of trivial                                   
considerations, sometimes misleading, that attempt to discredit our pioneering experimental                   
achievements, rather than contributing to its interpretation in an original and/or constructive                       
way. Moreover, the statement on the role of p-16O reaction and of the possible                           
radiosensibilisation of BSH via a not better specified “purely biochemical effect” (quoting                       
Mazzone et al, page 8 of the Discussion section”) clearly shows the lack of scientific arguments                               
in their tentative to explain our results, thus leading to a rather superficial vision of the authors                                 
of [2].   
Mazzone et al. compulsively put the emphasis only on the number of total produced alpha                             
particles and on the macroscopic concept of absorbed dose, completely forgetting to mention                         
that, for the interpretation of phenomena at cellular level, this approach is absolutely insufficient.                           
Dose is by definition a macroscopically non-stochastic quantity. However, at the nanoscale level,                         
i.e. that of relevance for DNA damage, hence for cellular effects, the concept of absorbed dose                               
falls short of explaining exhaustively a large number of phenomena as the intrinsically                         
 discontinuous pattern of energy deposition by charged particles becomes important, leading to a                         
inherently inhomogeneous biologically effective “dose” . With regard to this, they completely                       
miss to mention and discuss the role that microscopic quantities such as the LET, play at this                                 
level demonstrating either a complete lack of basic knowledge in the field or a visible ​mala fides​.                                 
Or both. 
Knowing that the physical considerations on the number of produced alphas reported by                         
Mazzone et al, besides trivial and obvious, are correct and shared by us, we hope that the next                                   
work on this important issue will not be written for the sole purpose to discredit another paper                                 
but with the desire (and capacity) to better understand and find explanations of these new                             
radiobiological phenomena. 
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